DiaMedica Therapeutics Inc.

DMAC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Aug 12, 2026
S-8 Aug 11, 2026 FORM S-8
10-Q Aug 10, 2026 FORM 10-Q
8-K Aug 10, 2026 FORM 8-K
4 Jun 3, 2026
4 Jun 3, 2026
4 Jun 3, 2026
4 Jun 3, 2026
4 Jun 3, 2026
4 Jun 3, 2026
4 Jun 3, 2026
4 Jun 3, 2026
4 Jun 3, 2026
8-K May 21, 2026 FORM 8-K
10-Q May 6, 2026 FORM 10-Q
8-K May 6, 2026 FORM 8-K
ARS Apr 1, 2026 ARS
DEFA14A Apr 1, 2026 FORM DEFA14A
DEF 14A Apr 1, 2026 FORM DEF 14A
8-K Mar 31, 2026 FORM 8-K
10-K Mar 30, 2026 FORM 10-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 6, 2026
4 Jan 6, 2026
← Newer Page 1 of 18 · 427 filings Older →